136 related articles for article (PubMed ID: 19814864)
1. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
Choi YH; Lee YS; Kim TK; Lee BY; Lee MG
J Pharm Pharmacol; 2009 Oct; 61(10):1325-32. PubMed ID: 19814864
[TBL] [Abstract][Full Text] [Related]
2. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541.
Choi YH; Lee YS; Lee MG; Kim TK; Lee BY
J Pharm Pharm Sci; 2010; 13(1):93-106. PubMed ID: 20456834
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
Lee YS; Choi YH; Kim TK; Ryu KH; Lee BY; Lee MG
Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
Lee DY; Kim JW; Lee MG
Eur J Pharm Sci; 2007 Dec; 32(4-5):328-39. PubMed ID: 17935951
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin.
Lee JH; Lee MG
Biopharm Drug Dispos; 2007 May; 28(4):157-66. PubMed ID: 17377958
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate.
Lee AK; Lee JH; Kwon JW; Kim WB; Kim SG; Kim SH; Lee MG
Biopharm Drug Dispos; 2004 Sep; 25(6):273-82. PubMed ID: 15334627
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic changes of drugs in rat model of acute renal failure induced by uranyl nitrate: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes.
Lee MG; Lee JH; Oh JM
Curr Clin Pharmacol; 2006 May; 1(2):193-205. PubMed ID: 18666371
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats.
Lee AK; Kim EJ; Lee MG
Res Commun Mol Pathol Pharmacol; 2003; 113-114():193-200. PubMed ID: 15686118
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of 2-(allylthio) pyrazine, a chemoprotective agent, in rats: the role of CYP3A23 induction.
Lee EJ; Kim EJ; Kim YG; Chung HC; Kim SH; Kim DH; Lees I; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():111-21. PubMed ID: 17564310
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
Choi YH; Lee YS; Bae SH; Kim TK; Lee BY; Lee MG
Biopharm Drug Dispos; 2009 Sep; 30(6):305-17. PubMed ID: 19639551
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.
Chung HJ; Lee MG
Biopharm Drug Dispos; 2006 Oct; 27(7):345-51. PubMed ID: 16902944
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, in spontaneously or DOCA-salt-induced hypertensive rats.
Lee YS; Choi YH; Yoon IS; Kim TK; Ryu KH; Lee BY; Lee MG
Biopharm Drug Dispos; 2011 Jan; 32(1):38-49. PubMed ID: 21162118
[TBL] [Abstract][Full Text] [Related]
14. Slower clearance of intravenous metformin in rats with acute renal failure induced by uranyl nitrate: contribution of slower renal and non-renal clearances.
Choi YH; Lee I; Lee MG
Eur J Pharm Sci; 2010 Jan; 39(1-3):1-7. PubMed ID: 19454315
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
[TBL] [Abstract][Full Text] [Related]
16. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
Lee DY; Lee MG; Shin HS; Lee I
J Pharm Pharm Sci; 2007; 10(4):420-33. PubMed ID: 18261364
[TBL] [Abstract][Full Text] [Related]
17. Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate.
Han SY; Yang SH; Yoon I; Lee MG; Choi YH
J Pharm Pharmacol; 2012 Oct; 64(10):1452-60. PubMed ID: 22943176
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in ondansetron pharmacokinetics in rats.
Yang SH; Yang KH; Lee MG
Biopharm Drug Dispos; 2008 Oct; 29(7):406-13. PubMed ID: 18696412
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG
J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.
Yang SH; Suh JH; Lee MG
Cancer Chemother Pharmacol; 2010 Feb; 65(3):407-18. PubMed ID: 19504095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
